Investor Relations LatestPress Releases Jul 10, 2024 Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024 Jun 26, 2024 Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update May 23, 2024 Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors btn News IR View All RecentEvents Jul 10, 2024 10 Jul 2024 at 8:30 AM EDT Second-Quarter Fiscal 2024 Financial Results Conference Call Listen to Webcast May 09, 2024 09 May 2024 at 10:00 AM EDT Annual Meeting of Shareholders Listen to Webcast Apr 10, 2024 10 Apr 2024 at 8:30 AM EDT First-Quarter Fiscal 2024 Financial Results Conference Call Listen to Webcast btn Events View All Financial InformationLatest Earnings Show all Q2 2024 Financial Statement 574.3 KB MD&A 873.6 KB btn QRs View More PresentationsInvestor Presentation Download PDF
Jul 10, 2024 Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024
Jun 26, 2024 Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update
May 23, 2024 Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors
Jul 10, 2024 10 Jul 2024 at 8:30 AM EDT Second-Quarter Fiscal 2024 Financial Results Conference Call Listen to Webcast
Apr 10, 2024 10 Apr 2024 at 8:30 AM EDT First-Quarter Fiscal 2024 Financial Results Conference Call Listen to Webcast